Skip to main content
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2003 Jul;18(2):209–215. doi: 10.1007/BF02867389

Evaluation of urinary abnormalities in urolithiasis patients: A study from North India

R Kumar 1, R Kapoor 1, B Mittal 2, A Kumar 1, R D Mittal 1,
PMCID: PMC3453874  PMID: 23105414

Abstract

Metabolic abnormalities were investigated in 44 stone patients with first time (group 1) and 56 with 2 times stone formation (group 2), and in 25 normal individuals. 24hr urine was analysed spectrophotometrically for oxalate, calcium, magnesium, citrate, uric acid, phosphate and creatinine. Hypocitraturia and hyperoxaluria were the common abnormalities in the stone formers. Stone patients had significantly higher urinary oxalate, calcium and uric acid and lower phosphate than normal individuals. Citrate/calcium and magnesium/calcium ratio were significantly high in normal individuals than stone formers. Patients in group 2 excreted significantly higher urinary calcium and lower citrate that patients in group 1. Citrate/calcium ratio was higher in group 1 than group 2. Hypocitraturia, hyperoxaluria, hypercalciuria and increased citrate/calcium and magnesium/calcium ratio seem to be an essential risk factor for stone formation. Patients with recurrent stone formation could be distinguished from patients with first time stone formation on the basis of urinary calcium and citrate.

Keywords: Recurrent stone formation, metabolic abnormality, hypercalciuria, hypocitraturia, hyperoxaluria

Full Text

The Full Text of this article is available as a PDF (444.6 KB).

References

  • 1.Bek-Jensen H., Tiselius H.G. Stone formation and urine composition in calcium stone formers without medical treatment. Eur. Urol. 1989;16:144–150. doi: 10.1159/000471553. [DOI] [PubMed] [Google Scholar]
  • 2.Borghi L., Schianchi T., Meschi T., Guerra T., Allegri F., Maggiore U., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl. J. Med. 2002;346:77–84. doi: 10.1056/NEJMoa010369. [DOI] [PubMed] [Google Scholar]
  • 3.Tiselius H.G. Recurrent stone formation in patients treated with extracorporeal shock wave lithotripsy. J. Stone Dis. 1992;4:152–157. [Google Scholar]
  • 4.Ahlstrand C., Tiselius H.G. Recurrence during a 10-year follow-up period after first renal stone episode. Urol. Rev. 1990;18:397–399. doi: 10.1007/BF00297372. [DOI] [PubMed] [Google Scholar]
  • 5.Sun B.Y.C., Lee Y.H., Jiaan B.P., et al. Recurrence rate and risk factors for urinary calculi after extracorporeal shock wave lithotripsy. J. Urol. 1998;140:479–483. [PubMed] [Google Scholar]
  • 6.Yu C.C., Lee Y.H., Huang J.K., Chen M.T., Chen K.K., Lin A.T., et al. Long-term stone re-growth and recurrence rates after extracorporeal shock wave lithotripsy. Br. J. Urol. 1993;72:688–691. doi: 10.1111/j.1464-410X.1993.tb16248.x. [DOI] [PubMed] [Google Scholar]
  • 7.Fine J.K., Pak C.Y.C., Preminger G.M. Effect of medical management and residual fragments on recurrence stone formation following shock wave lithotripsy. J. Urol. 1995;153:27–33. doi: 10.1097/00005392-199501000-00010. [DOI] [PubMed] [Google Scholar]
  • 8.Streem S.B. Long-term incidence and risk factors for recurrent stones following percutaneous nephrolithotomy or percutaneous nephrolithotomy/extracorporeal shock wave lithotripsy for infection related calculi. J. Urol. 1995;153:584–587. doi: 10.1016/S0022-5347(01)67653-5. [DOI] [PubMed] [Google Scholar]
  • 9.Frauscher F., Klauser A., Halpern E.J. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001;358(9282):651–6. doi: 10.1016/S0140-6736(01)05782-8. [DOI] [PubMed] [Google Scholar]
  • 10.Rajagopal G. A simple colorimetric procedure for estimation of citric acid in urine. Ind. J. Exp. Biol. 1985;22:391–2. [PubMed] [Google Scholar]
  • 11.Curhan G., Rimm E., Willett W., Sampfer M.J. Regional variation between nephrolithiasis incidence and prevalence among United States men. J. Urol. 1994;151:838–841. doi: 10.1016/s0022-5347(17)35101-7. [DOI] [PubMed] [Google Scholar]
  • 12.Soucie J.M., Coates R.J., McClellan W., Austin H., Thun M. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am. J. Epidemiol. 1990;143:487–495. doi: 10.1093/oxfordjournals.aje.a008769. [DOI] [PubMed] [Google Scholar]
  • 13.Yagisawa T., Hayashi T., Yoshida A., Kobayashi C., Okuda H., Ishikawa N., et al. Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender. Eur. Urol. 2000;38:297–301. doi: 10.1159/000020296. [DOI] [PubMed] [Google Scholar]
  • 14.Borghi L., Meschi T., Amato F., Briganti A., Novarini A., Giannini A. Urinary volume, water and recurrence in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J. Urol. 1996;155:839–843. doi: 10.1016/S0022-5347(01)66321-3. [DOI] [PubMed] [Google Scholar]
  • 15.Schwitle P.O., Schmiedl A., Hersmann U., Fan J., Gottlieb D., Manoharan M. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis. Urol. Res. 1999;27(2):117–26. doi: 10.1007/s002400050097. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES